Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004844760 | SCV005468711 | uncertain significance | not specified | 2024-07-17 | criteria provided, single submitter | clinical testing | The c.2534G>A (p.G845D) alteration is located in exon 21 (coding exon 20) of the PIWIL3 gene. This alteration results from a G to A substitution at nucleotide position 2534, causing the glycine (G) at amino acid position 845 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |